Outcomes of Ahmed and Baerveldt Glaucoma Drainage Devices in Japanese Patients
Tomoyo Hara1,2, Hanako O Ikeda1,3, Shogo Numa1
1Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto.
Insights
This study found no significant differences in surgical outcomes between the Ahmed glaucoma valve and Baerveldt glaucoma implant. However, the Baerveldt implant had more complications, particularly hypotony.
Area of Science:
- Ophthalmology
- Glaucoma Surgery
- Medical Device Evaluation
Background:
- Glaucoma surgery aims to reduce intraocular pressure (IOP) and prevent vision loss.
- Tube-shunt surgery is a common treatment for refractory glaucomas.
- The Ahmed glaucoma valve and Baerveldt glaucoma implant are widely used devices.
Purpose of the Study:
- To compare the preoperative conditions and surgical outcomes of the Ahmed glaucoma valve and Baerveldt glaucoma implant.
- To evaluate the incidence of complications associated with each device in clinical practice.
Main Methods:
- Retrospective analysis of 154 eyes undergoing glaucoma tube-shunt surgery between 2015 and 2021.
- Exclusion of patients with prior glaucoma tube shunt surgeries.
- Data collection included preoperative conditions, IOP, medication scores, visual acuity, and complications.
Main Results:
- No significant differences in IOP or medication scores were observed at 36 months between the Ahmed glaucoma valve and Baerveldt glaucoma implant groups.
- Cumulative success rates at 60 months were similar for both devices under different IOP definitions.
- The Baerveldt glaucoma implant group showed a higher incidence of postoperative complications, primarily hypotony.
Conclusions:
- Both the Ahmed glaucoma valve and Baerveldt glaucoma implant demonstrate comparable long-term surgical outcomes.
- Implant choice is influenced by glaucoma type and patient's surgical history.
- The Baerveldt glaucoma implant is associated with a higher rate of complications, notably hypotony.
PréCis:
Preoperative conditions and outcomes of the Ahmed glaucoma valve and Baerveldt glaucoma implant were assessed. Differences were observed in disease type and surgical history between the 2 groups. Comparatively, the Baerveldt glaucoma implant had more complications.
Purpose:
To evaluate the preoperative conditions and surgical outcomes of the Ahmed glaucoma valve and the Baerveldt glaucoma implant in clinical practice.
Patients And Methods:
Patients who underwent glaucoma tube-shunt surgery using the Ahmed glaucoma valve or Baerveldt glaucoma implant at Kyoto University Hospital between January 1, 2015, and December 31, 2021, were included. Patients with previous glaucoma tube shunt surgeries were excluded. Data on preoperative conditions, intraocular pressure, glaucoma medication scores, visual acuity, and complications were retrospectively obtained from medical records.
Results:
We analyzed 154 eyes (Ahmed glaucoma valve, 102 eyes; Baerveldt glaucoma implant, 52 eyes) in total. No significant differences were observed between the groups except for disease type and surgical history-neovascular glaucoma and no prior glaucoma surgery were more common in the Ahmed glaucoma valve group, whereas exfoliation glaucoma, primary open angle glaucoma, and history of glaucoma surgery were more frequent in the Baerveldt glaucoma implant group. At 36 months, mean intraocular pressure and medication scores were 14.2±4.0 mm Hg and 2.1±1.5 for Ahmed glaucoma valve, and 13.0±4.6 mm Hg and 1.7±1.7 for Baerveldt glaucoma implant, respectively, with no significant differences. The 60-month cumulative success rates were 58.1% for Ahmed glaucoma valve and 60.6% for Baerveldt glaucoma implant under Definition A (intraocular pressure range: 6-21 mm Hg) and 57.5% for Ahmed glaucoma valve and 57.5% for Baerveldt glaucoma implant under Definition B (intraocular pressure range: 6-18 mm Hg). The Baerveldt Glaucoma Implant group revealed a higher incidence of postoperative complications, with hypotony being the most common complication.
Conclusion:
In this large-scale real-world study, no significant differences in surgical outcomes were observed between the Ahmed glaucoma valve and the Baerveldt glaucoma implant. However, it should be noted that the implant choice tended to be influenced by glaucoma type and surgical history, reflecting differences in disease background between the treatment groups.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment


